United Therapeutics Corpo...

NASDAQ: UTHR · Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT

United Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.24B 1.21B 1.2B 1.11B 1.07B 1.05B 984.8M 899.8M 871.5M 728.3M 727.3M 707.4M 630.8M 687.4M 475.8M 462.4M 470.9M 405.4M
Depreciation & Amortization
79.7M 77.3M 72.5M 66.5M 60.7M 54.9M 53.2M 52.7M 52.3M 52.1M 51.3M 50.7M 50.2M 49.9M 49.9M 50.4M 49.8M 50M
Stock-Based Compensation
138.3M 150.2M 144M 133.6M 113M 77.1M 39.1M 87.3M 63.8M 115.5M 106.8M 86.7M 113.7M 77.3M 138.5M 187.5M 150.4M 173.1M
Other Working Capital
139.8M 3.4M -55.6M -59.8M -106.5M -48.3M -126.6M -179.6M -146M -198.3M -150.6M -68.9M -116.8M -57.8M -112.9M -144.3M -106.8M -55.3M
Other Non-Cash Items
-175.6M -900K -20.8M -23.2M 18.3M -17M 114.1M 102M 72.6M 108.2M 23.9M 90.8M 94.9M 59.8M 72.5M 37M 94.4M 175.5M
Deferred Income Tax
n/a -3.5M -3.5M -3.5M -6M -5.7M -76.7M -138.9M -75.1M -130M -71.7M -9.5M -70.8M -12.7M n/a n/a n/a n/a
Change in Working Capital
86.8M -22M -60.2M -147.7M -149.8M -180.1M -136.5M -47.4M -117.2M 14.5M -35.1M -18.5M -7.1M -29.1M -48.8M -68.7M -1M 10.6M
Operating Cash Flow
1.37B 1.41B 1.33B 1.14B 1.11B 979.7M 978M 955.5M 867.9M 888.6M 802.5M 848.9M 775.9M 797.1M 598.2M 549.8M 615.1M 630.9M
Capital Expenditures
-300.3M -283.2M -246.5M -238.5M -227.7M -227.3M -230.4M -191.2M -194.3M -166.6M -138.8M -169.9M -124.4M -123.7M -120.8M -62.5M -55M -56.9M
Cash Acquisitions
n/a n/a n/a -89.2M 147.9M 326.7M 506.5M 604.3M 390.9M 364.1M 530M 521.4M 497.7M 345.7M n/a n/a n/a n/a
Purchase of Investments
-3.39B -1.81B -1.65B -1.48B -1.71B -2.15B -2.51B -2.64B -2.26B -2.12B -1.71B -1.77B -2.03B -1.81B -1.9B -2.01B -2.08B -2.39B
Sales Maturities Of Investments
1.78B 1.67B 2.37B 2.42B 2.44B 2.73B 2.14B 1.88B 1.72B 1.6B 1.03B 1.13B 1.19B 1.1B 1.53B 1.72B 1.75B 1.73B
Other Investing Acitivies
1.2B -63.4M -58.5M -31.2M -261.1M -443.2M -618.7M -606.5M -384M -353.5M -519.4M -648.1M -835.5M -716.1M -366.1M -292.4M -335.7M -660.3M
Investing Cash Flow
-702.7M -482.8M 417.2M 582.5M 384M 236.8M -719.6M -951M -731.6M -673.4M -811.5M -818M -959.9M -839.8M -486.9M -354.9M -390.7M -717.2M
Debt Repayment
-300M -400M -400M -400M -300M -200M -100M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-16M -27.5M -1.01B -1.01B -1.01B -1.01B -27.3M -15.8M -15.9M -2.4M n/a -11.6M -11.5M -11.7M -10.8M -10.7M -10.6M -10.5M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-152M 46.5M 93.8M 75.5M 47M 71.8M 88.4M 136.6M 136.1M 135.3M 86.8M 39M 48.5M 35.4M 55.6M 54.1M 43M 53.9M
Financial Cash Flow
-431.2M -280.6M -1.25B -1.27B -1.2B -1.13B -11.9M 136.4M 135.8M 135M 75.4M 27.4M 37M 23.7M 44.8M 43.4M 32.4M 43.4M
Net Cash Flow
237.4M 648.4M 489.5M 446.2M 288.4M 88M 246.5M 140.9M 272.1M 350.2M 66.4M 58.3M -147M -19M 156.1M 238.3M 256.8M -42.9M
Free Cash Flow
1.07B 1.13B 1.08B 898.1M 877.9M 752.4M 747.6M 764.3M 673.6M 722M 663.7M 679M 651.5M 673.4M 477.4M 487.3M 560.1M 574M